In VitroHighlightedTherapeutic efficacy of hydrogen‑rich saline alone and in combination with PI3K inhibitor in non‑small cell lung cancerMHID-1525156PMID: 299011392018Molecular Medicine ReportsYU JIANG, GANG LIU, LI ZHANG, SHENG CHENG, CHUN LUO, YANG LIAO, et al.The aim of the present study was to investigate the effects of combination therapy of LY294002, a specific inhibitor of phosphatidylinositol 3‑kinase (PI3K), with hydrogen‑rich saline on the proliferation and apoptosis of the non‑small cell lung cancer (NSCLC) A549 cell line and the mechanisms underpinning this. Excessive production of reactive oxygen species (ROS) may induce DNA mutations, DNA d